News
May 7, 2025Lantheus Holdings, Inc. misses on earnings expectations. Reported EPS is $1.53 EPS, expectations were $1.68. Operator: Good morning. Welcome to the Lantheus First Quarter 2025 Conference ...
LMI will provide Lantheus with a commercial radiodiagnostic Alzheimer’s franchise, a talented team, and NEURACEQ, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in ...
Q1 2025 Earnings Call Transcript May 12, 2025 FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $0.03. Operator: Good day and thank you for standing by.
Macy Ringlein, a senior at Kearney Catholic High School, has worked part-time and volunteered at the World Theater while ...
A special imaging procedure, amino acid PET, can not only improve patient care, but also advance research into the development of new treatment approaches. The first standardized criteria for the use ...
The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.
Cubresa’s NuPET™ is a revolutionary in-bore PET scanner that inserts into existing MRI instruments to create a powerful and flexible hybrid preclinical in vivo imaging platform that combines ...
1d
Zacks Small Cap Research on MSNRADX: Initiating Coverage – Adding a Radioisotope to Precision OncologyRADX READ THE FULL RADX RESEARCH REPORT We are initiating coverage of Radiopharm Theranostics Limited (NASDAQ:RADX) and assign a valuation of $12.50 per American Depository Receipt (ADR). This ...
HUNTSVILLE, Ala. (WHNT) — All over the Tennessee Valley, furry friends are looking for their forever homes. This week, we are featuring another dog from the Greater Huntsville Humane Society ...
Participants will enroll in one of the five NIA-funded Alzheimer’s disease research centers to complete neurological, cognitive and neuropsychiatric exams, multimodal brain imaging, tau PET ...
an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions ...
As of May 3, UW-Madison has been ordered to stop work on three federally funded projects and told to stop work on 10 others ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results